The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.82BCNY
463.97M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
485.94MCNY
47.63M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-1.83%
vs Medical Devices peers
Updated Nov 22, 2026
Beta
0.2900x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-30.93%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
2.82BCNY
463.97M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
3.70BCNY
339.20M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
20.72x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Sales (TTM)
5.80x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Book (MRQ)
1.71x
vs Medical Devices peers
Updated Nov 22, 2026
Enterprise to Revenue
7.62x
vs Medical Devices peers
Updated Nov 22, 2026
Gross Margin
43.49%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 54.03%.Updated Nov 22, 2026
Profit Margin
-1.83%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Margin
0.94%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Assets (TTM)
0.11%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Equity (TTM)
0.37%
vs Medical Devices peers
Updated Nov 22, 2026
Revenue (TTM)
485.94MCNY
47.63M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
0.8900CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
183.30%
vs Medical Devices peers
Updated Nov 22, 2026
Gross Profit (TTM)
262.57MCNY
20.37M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
36.44MCNY
5.46M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-8.91MCNY
-3.87M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
3.28%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
75.16MCNY
5.63M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
-698.64MCNY
5.29M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.17%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
1250.00%
vs Medical Devices peers
Updated Nov 22, 2026
Minority Interest (Equity)
31.62MCNYFY2025 · Dec 31, 2025
Revenue
326.31MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
162.83MCNYFY2025 · Dec 31, 2025
Gross Profit
163.48MCNYFY2025 · Dec 31, 2025
Operating Income
-23.52MCNY
-3.52M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-17.54MCNYFY2025 · Dec 31, 2025
Income Tax Expense
6.11MCNYFY2025 · Dec 31, 2025
Net Income
-23.65MCNYFY2025 · Dec 31, 2025
EBIT
-17.35MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
36.44MCNYFY2025 · Dec 31, 2025
Research & Development
24.12MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
40.15MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.01MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.57MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
192.91KCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.0400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.0400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
574.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
574.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-23.65MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
665.72KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-21.01MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-38.09MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
514.84MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-23.65MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.75MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
4.47MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-9.59MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-17.08MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-884.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
825.10MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-75.98MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-2.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.47MCNYFY2025 · Dec 31, 2025
Shares Outstanding
544.01MSharesUpdated Nov 22, 2026
Float Shares
290.74MSharesUpdated Nov 22, 2026
% Held by Insiders
50.73%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
0.56%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
574.79MCNY
137.29M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
1.06CNYUpdated Nov 22, 2026
Total Debt (MRQ)
982.81MCNY
404.41K · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.4631x
vs Medical Devices peers
Updated Nov 22, 2026
Current Ratio (MRQ)
4.28x
vs Medical Devices peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
3.03CNYUpdated Nov 22, 2026
Total Assets
1.78BCNY
266.23M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.10BCNYFY2025 · Dec 31, 2025
Total Liabilities
105.46MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
674.14MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
18.73MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
86.73MCNYFY2025 · Dec 31, 2025
Cash
566.02MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.10KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
566.02MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
336.75MCNYFY2025 · Dec 31, 2025
Accounts Receivable
85.87MCNYFY2025 · Dec 31, 2025
Inventory
88.72MCNYFY2025 · Dec 31, 2025
Accounts Payable
20.72MCNYFY2025 · Dec 31, 2025
Short-term Debt
3.04MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.92MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.16MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
664.65KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
544.01MCNYFY2025 · Dec 31, 2025
Retained Earnings
409.41MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.67BCNY
250.43M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.18CNYUpdated Nov 22, 2026
52-Week High
8.27CNYUpdated Nov 22, 2026
52-Week Change
-30.93%
vs all stocks
Updated Nov 22, 2026
Beta
0.2900x
vs all stocks
Updated Nov 22, 2026
50-Day MA
5.88CNYUpdated Nov 22, 2026
200-Day MA
6.15CNYUpdated Nov 22, 2026
Avg 10-Day Volume
8.02MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
10.11MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.0100CNYUpdated Nov 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 14.67×, higher than 95% of its Medical Devices peers (median 3.82×)Significant
Current ratio: 14.67Industry median: 3.82Industry P95: 11.74Peers compared: 105
Debt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)Notable